Thane Wettig
CEO at Fibrogen Inc (KYNB); CEO at Kyntra Bio, Inc. (KYNB)
Purchase track record
Below average. Based on 2 purchases with a full 90 days of price history.
31
Avg. 90-day return-7.8%
vs. S&P 500-12.0%
Beat the market0%
Paper profit on buys−$17K
Total bought / sold$73K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 19SEC | KYNBKyntra Bio, Inc. | Buy | 2,80027,203 held (+11%) | $7.09 | $20K | -13.8% |
| May 18SEC | KYNBKyntra Bio, Inc. | Buy | 2,80027,203 held (+11%) | $7.09 | $20K | -13.8% |
| Nov 17SEC | KYNBFibrogen Inc | Buy | 1,00022,239 held (+5%) | $9.18 | $9K | -33.4% |
| Nov 17SEC | KYNBFibrogen Inc | Buy | 2,70024,939 held (+12%) | $9.10 | $25K | -32.9% |
- Buy
CEO Thane Wettig bought $9K of KYNB at $9.18 — first open-market purchase in our records.
- Buy
CEO Thane Wettig bought $25K of KYNB at $9.10 — largest purchase by this insider in our records.